Literature DB >> 30202622

The use of in vitro maturation in stimulated antagonist in vitro fertilization cycles of normo-hyperresponder women due to arrested follicular development: A rescue procedure.

Şafak Hatırnaz1, Süleyman Akarsu2, Ebru Saynur Hatırnaz1, Ahmet Zeki Işık3, Michael Haim Dahan4.   

Abstract

Objective: To evaluate the impact of rescue in vitro maturation (IVM) on the clinical outcomes of women with arrested follicular development in stimulated in vitro fertilization (IVF) cycles. Materials and
Methods: This is a retrospective review of 13 patients who were evaluated as normo-hyperresponders for ovarian stimulation. The main outcome measure was the clinical pregnancy and livebirth rates. The purpose of gonadotropin stimulation in patients undergoing IVF is to retrieve multiple oocytes by avoiding multifetal gestation and Ovarian Hyperstimulation syndrome (OHSS). The ovarian response to stimulation ranges from poor response to OHSS, which is related to the follicular number and the dose of the gonadotropins used. However, in some cycles of normo-hyperresponder women, follicular development decelerates or ceases. Close follow-up in a daily manner and increasing the dose of gonadotropins did not change the follicular arrest. This clinical situation has two edges; one is cycle cancellation, which has undesired psychological outcomes for women and the IVF team, and second one is the prolongation of the IVF cycle. For such circumstances, IVM may be a valuable option. Stimulated IVF cycles were converted to IVM as a rescue IVM procedure following detailed informed consent of the women who were close to cycle cancellation.
Results: Thirteen 13 IVM cycles and their clinical outcomes are presented. Six women achieved pregnancies, but only 4 delivered 5 healthy live born. The other two women had biochemical loss during follow-up.
Conclusion: Based on the data obtained, it can be concluded that gonadotropin-stimulated cycles with follicular arrest at the edge of cancellation can be shifted to rescue IVM procedures with reasonable clinical outcomes.

Entities:  

Keywords:  Rescue; cycle cancellation; in vitro fertilization; in vitro maturation; pregnancy rate

Year:  2018        PMID: 30202622      PMCID: PMC6127470          DOI: 10.4274/tjod.22804

Source DB:  PubMed          Journal:  Turk J Obstet Gynecol        ISSN: 2149-9330


  34 in total

1.  Are minimal stimulation IVF and IVM set to replace routine IVF?

Authors:  R G Edwards
Journal:  Reprod Biomed Online       Date:  2007-02       Impact factor: 3.828

Review 2.  Oocyte in vitro maturation in normo-ovulatory women.

Authors:  Rubens Fadini; Mario Mignini Renzini; Mariabeatrice Dal Canto; Amalia Epis; Marilena Crippa; Ilaria Caliari; Claudio Brigante; Giovanni Coticchio
Journal:  Fertil Steril       Date:  2013-02-20       Impact factor: 7.329

3.  Contribution of in-vitro maturation in ovarian stimulation cycles of poor-responder patients.

Authors:  Daniela Paes de Almeida Ferreira Braga; Rita de Cássia Sávio Figueira; Renata Cristina Ferreira; Fabio Firmbach Pasqualotto; Assumpto Iaconelli; Edson Borges
Journal:  Reprod Biomed Online       Date:  2009-12-16       Impact factor: 3.828

4.  Multinucleation and cleavage of embryos derived from in vitro-matured oocytes.

Authors:  Veljko Vlaisavljević; Mojca Cizek-Sajko; Vilma Kovac
Journal:  Fertil Steril       Date:  2006-06-12       Impact factor: 7.329

5.  Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study.

Authors:  R Fadini; M B Dal Canto; M Mignini Renzini; F Brambillasca; R Comi; D Fumagalli; M Lain; M Merola; R Milani; E De Ponti
Journal:  Reprod Biomed Online       Date:  2009-09       Impact factor: 3.828

6.  Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation.

Authors:  P Wynn; H M Picton; J A Krapez; A J Rutherford; A H Balen; R G Gosden
Journal:  Hum Reprod       Date:  1998-11       Impact factor: 6.918

7.  Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program.

Authors:  K Y Cha; J J Koo; J J Ko; D H Choi; S Y Han; T K Yoon
Journal:  Fertil Steril       Date:  1991-01       Impact factor: 7.329

Review 8.  Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysis.

Authors:  M Kollmann; W P Martins; M L S Lima; L Craciunas; C O Nastri; A Richardson; N Raine-Fenning
Journal:  Ultrasound Obstet Gynecol       Date:  2016-10-27       Impact factor: 7.299

9.  THE COMPARATIVE BEHAVIOR OF MAMMALIAN EGGS IN VIVO AND IN VITRO : I. THE ACTIVATION OF OVARIAN EGGS.

Authors:  G Pincus; E V Enzmann
Journal:  J Exp Med       Date:  1935-10-31       Impact factor: 14.307

Review 10.  In Vitro Maturation in Women with vs. without Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Charalampos Siristatidis; Theodoros N Sergentanis; Paraskevi Vogiatzi; Prodromos Kanavidis; Charalampos Chrelias; Nikolaos Papantoniou; Theodora Psaltopoulou
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

View more
  3 in total

1.  Early oocyte triggering followed by in vitro maturation is a good approach in women with resistance ovary syndrome: A case-series.

Authors:  Maryam Eftekhar; Banafsheh Mohammadi; Nasim Tabibnejad; Mohammad Hossein Razi
Journal:  Int J Reprod Biomed       Date:  2021-07-27

2.  Analysis of maturation dynamics and developmental competence of in vitro matured oocytes under time-lapse monitoring.

Authors:  Qiyu Yang; Lixia Zhu; Meng Wang; Bo Huang; Zhou Li; Juan Hu; Qingsong Xi; Jing Liu; Lei Jin
Journal:  Reprod Biol Endocrinol       Date:  2021-12-10       Impact factor: 5.211

3.  Rescue IVM of Denuded GV- and MI-Stage Oocytes of Premenopausal Rats with Oncostatin M, Insulin-like Growth Factor I, and Growth Hormone.

Authors:  Yesim Akdemir; Yaprak Donmez Cakil; Belgin Selam; Mustafa Erinc Sitar; Mehmet Cincik
Journal:  Life (Basel)       Date:  2022-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.